This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Healthcare Q2 Earnings Slated on Jul 25: HCA, UHS & More
by Zacks Equity Research
The healthcare sector continues to benefit from higher enrollments, mergers and acquisitions, partly offset by high expense on account of acquisition integration and investments in technology.
Universal Health (UHS) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Universal Health's (UHS) second-quarter earnings are likely to be boosted by solid revenue growth. However, increasing cost of debt might hurt the bottom line.
Obamacare Replacement Bill Revised: Hospital Stocks in Focus
by Zacks Equity Research
Senate Republican leaders released a revised plan for President Donald Trump's health care reform on Jul 13.
LifePoint (LPNT) Thriving on Inorganic Growth, Ample Capital
by Zacks Equity Research
LifePoint Health Inc. (LPNT) is well poised to grow over the long term given a number of acquisitions made over the past few years.
Senate Unveils Its Version of Trumpcare: Healthcare Stocks Up
by Arpita Dutt
Healthcare stocks were up yesterday following the release of the 142-page Better Care Reconciliation Act of 2017.
Could Universal Health (UHS) Be a Great Stock for Value Investors?
by Zacks Equity Research
Universal Health is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Universal Health Grows on Acquisitions, Rising Debt a Drag
by Zacks Equity Research
Universal Health Services, Inc.'s (UHS)s inorganic strategies substantially make it well positioned for long-term growth.
Ensign Group (ENSG) Continues to Grow on Inorganic Path
by Zacks Equity Research
The Ensign Group, Inc. (ENSG) has acquired the real estate and operations of three skilled nursing and one intermediate care facilities across Idaho and Utah.
Community Health (CYH) Continues to Divest, Aligns Business
by Zacks Equity Research
Community Health Systems, Inc. (CYH) has signed a definitive agreement to sell five Pennsylvania hospitals.
Universal Health (UHS) Down 2% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Universal Health (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HCA Healthcare Grows on Buyouts, Commercial Business Bothers
by Zacks Equity Research
HCA Healthcare (HCA), one of the most diversified hospital companies in the U.S. was still recently known as HCA Holdings.
Acadia Healthcare (ACHC) Q1 Earnings In Line, View Intact
by Zacks Equity Research
Acadia Healthcare Company Inc. (ACHC) reported first-quarter 2017 adjusted earnings of 46 cents per share, meeting the Zacks Consensus Estimate.
Universal Health (UHS) Beats on Q1 Earnings, Misses Revenues
by Zacks Equity Research
Universal Health Services Inc. (UHS) reported first-quarter 2017 adjusted earnings of $2.10 per share that surpassed the Zacks Consensus Estimate by 1.9%.
Universal Health Services (UHS) Reports Mixed Q1 Results
by Joseph Lu
Universal Health Services Inc. (UHS) just released its financial results for the first quarter of 2017, posting earnings of $2.10 per share and revenues of $2.61 billion. Currently, UHS is a Zacks Rank #3 (Hold) and is up 0.43% to $121.42 per share in trading shortly after its earnings report was released.
Healthcare Earnings to Watch on Apr 25: ACHC, CNC & UHS
by Zacks Equity Research
The Healthcare sector has been in limelight since the change of power at the White House.
Ensign Group (ENSG) Buys a 74-Bed Facility to Expand in Iowa
by Zacks Equity Research
The Ensign Group, Inc. (ENSG) has acquired the Rehabilitation Center of Des Moines -- a skilled nursing operation with 74 beds.
Is Universal Health Services a Good Pick for Value Investors?
by Zacks Equity Research
Value investing is easily one of the most popular ways to find great stocks in any market environment.
Is it Wise to Hold Universal Health (UHS) in Your Portfolio?
by Zacks Equity Research
Headquartered in King of Prussia, PA, Universal Health Services Inc. (UHS) stock has gained 12.8% year to date, significantly higher than the increase of 7.6% witnessed by the Zacks categorized medical sector.
Are Hospital Stocks in Trouble if Obamacare Is Replaced?
by Zacks Equity Research
The Trump administration is steadily moving toward restructuring the federal health-care law.
The Zacks Analyst Blog Highlights: Acadia Healthcare, VCA, Universal Health Services and Mednax
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Acadia Healthcare, VCA, Universal Health Services and Mednax
Obamacare Replacement: A Threat to Hospital Stocks?
by Zacks Equity Research
Following the recent presentation of draft legislation by the Republicans to repeal and replace ObamaCare or Affordable Care Act (ACA), most of the market analysts opined that the new plan will lead to a massive decline in the number of insured people.
Universal Health (UHS) Beats on Q4 Earnings, Gives '17 View
by Zacks Equity Research
Universal Health's (UHS) better-than-expected fourth quarter earnings was driven by revenue growth.
4 Reasons Why HCA Holdings (HCA) is an Attractive Choice
by Zacks Equity Research
HCA Holdings Inc. (HCA) still remains a solid bet owing to its vast scale, operational strength and strong cash flows.
Universal Health (UHS) Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Universal Health Services, Inc. (UHS) will release fourth-quarter 2016 results on Feb 28, after the market closes. Last quarter, the company posted a negative earnings surprise of 4.19%.
Moody's Jumps into Action as Aetna-Humana Deal Fails
by Zacks Equity Research
After the merger deal between Aetna Inc. (AET) and Humana Inc. (HUM) fell through, rating agency Moody's Investors Service jumped into action